Oncolytic herpes simplex virus and immunotherapy

Overview of attention for article published in BMC Immunology, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 16,642 followers.

Si tenéis curiosidad, aquí podéis profundizar en algunos de los temas https://t.co/Tgkt4qByv7 https://t.co/UEGnqLzULL https://t.co/9afXYTzQPT

RT @profahdal: Oncolytic herpes simplex virus and immunotherapy https://t.co/GNMmaGuLzW #bmcimmunol

RT @profahdal: Oncolytic herpes simplex virus and immunotherapy https://t.co/GNMmaGuLzW #bmcimmunol

RT @profahdal: Oncolytic herpes simplex virus and immunotherapy https://t.co/GNMmaGuLzW #bmcimmunol

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.